ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Funding For Groups, Working With Industry, Still Unresolved

June 12, 1998

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

Robert Cook-Deegan On Implications of Appelate Court Ruling In Myriad Case Ruling

August 5, 2011

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001

In Brief: USC Norris Opens Topping Tower March 21; Postal Service To Sell Breast Cancer Stamps

March 15, 1996